Trial reportJournal of the International Society of Sports Nutrition2026
Effects of the micronutrient Sanopal® (5-hydroxymethyl-2-furfural and α-ketoglutaric acid) on oxygen affinity of hemoglobin, oxygen saturation and exercise responses at altitude.
Trial report in Journal of the International Society of Sports Nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith increasing altitude, the partial pressure of oxygen and oxygen saturation (SpO
methodsNineteen healthy young sports students (12 females, 7 males) participated in a single-blinded, placebo-controlled crossover study investigating the effects of Sanopal® at low (590 m) and moderate altitude (2900 m). Participants received Sanopal® or placebo in a randomized order, with measurements of SpO₂, heart rate, and blood parameters taken before and after ingestion, as well as before and after exercise at altitude.
resultsUnder resting and acute hypoxia conditions, Sanopal® did not increase hemoglobin-oxygen affinity or SpO₂. At altitude and post-exercise, Hb-O₂ affinity decreased by approximately 5% in the PL trial but increased by approximately 2% in the SA session (interaction effect:
conclusionsSanopal® did not alter hemoglobin-oxygen affinity or SpO₂ under resting conditions in normoxia or acute hypoxia. After exercise at altitude, it slightly increased Hb-O₂ affinity without significantly affecting SpO₂ or other measured blood parameters. The modest increase in Hb-O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.